Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.73
-0.64 (-6.83%)
At close: Nov 20, 2024, 4:00 PM
8.90
+0.17 (1.95%)
After-hours: Nov 20, 2024, 7:14 PM EST
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 452 employees as of December 31, 2023. The number of employees increased by 340 or 303.57% compared to the previous year.
Employees
452
Change (1Y)
340
Growth (1Y)
303.57%
Revenue / Employee
$58,119
Profits / Employee
-$750,985
Market Cap
596.93M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 452 | 340 | 303.57% |
Dec 31, 2022 | 112 | 35 | 45.45% |
Dec 31, 2021 | 77 | 22 | 40.00% |
Dec 31, 2020 | 55 | 30 | 120.00% |
Dec 31, 2019 | 25 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Standard BioTools | 539 |
Axogen | 428 |
IGM Biosciences | 224 |
Stoke Therapeutics | 110 |
ORIC Pharmaceuticals | 100 |
Altimmune | 59 |
Immunome | 55 |
Dianthus Therapeutics | 53 |
PHAT News
- 11 days ago - Phathom Pharmaceuticals, Inc. (PHAT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 24 days ago - Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024 - GlobeNewsWire
- 24 days ago - Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting - GlobeNewsWire
- 3 months ago - Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 3 months ago - Phathom Pharmaceuticals, Inc. (PHAT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults - GlobeNewsWire